An open label study to evaluate the effects on Mycobacterium tuberculosis, safety, tolerability and pharmacokinetics of single doses of R207910, in treatment naive patients with mycobacterium tuberculosis infection.

Trial Profile

An open label study to evaluate the effects on Mycobacterium tuberculosis, safety, tolerability and pharmacokinetics of single doses of R207910, in treatment naive patients with mycobacterium tuberculosis infection.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 26 Jul 2011

At a glance

  • Drugs Bedaquiline (Primary)
  • Indications Tuberculosis
  • Focus Therapeutic Use
  • Sponsors Janssen R&D Ireland
  • Most Recent Events

    • 26 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top